What if it were possible to combine the technological capabilities of an entire laboratory on one single chip? Scientists all across Europe may be getting close. Scientists at…
NEW YORK (Reuters Health) – Even the best strategies for selectively testing colorectal CRC tumors for mismatch repair (MMR) gene mutations will miss 5% to 15% of Lynch…
NEW YORK (Reuters Health) – Getting a second opinion of surgical breast pathology often leads to changes that impact treatment in women with node-negative breast cancer or ductal…
NEW YORK (Reuters Health) – Compared with antenatal vaginal cultures, intrapartum PCR screening for maternal group B streptococcal colonization reduces the rate of neonatal GBS disease, a French…
NEW YORK (Reuters Health) – While first-void urine specimens have been used traditionally to test for Chlamydia trachomatis, newer DNA detection methods produce reliable results using midstream specimens,…
NEW YORK (Reuters Health) – In patients presenting with chest pain, troponin I levels measured on admission and at 3 hours reliably rule out or rule in acute…
NEW YORK (Reuters Health) – Testing for autoantibody against the 155-kDa protein is a “highly accurate” tool for diagnosing cancer-associated myositis in adults with dermatomyositis, according to a…
NEW YORK (Reuters Health) – The Oncotype DX test, based on reverse transcription polymerase chain reaction (RT-PCR), for HER2 gene amplification in breast cancers has an “unacceptable” false-negative…
NEW YORK (Reuters Health) – While real-time polymerase chain reaction (RT-PCR) testing is sensitive and rapid in diagnosing the cause of acute respiratory infection in children, it does…
NEW YORK (Reuters Health) – Quantitative Pneumocystis jirovecii (Pj) PCR can be a valuable diagnostic tool in immunocompromised non-HIV patients, Swiss researchers report in a September 15th on-line…
